EP Patent

EP3381943A1 — Anti-kit antibodies and uses thereof

Assigned to Celldex Therapeutics Inc · Expires 2018-10-03 · 8y expired

What this patent protects

The present invention provides an antibody, or an antigen-binding fragment thereof, which immunospecifically binds to human KIT, polynucleotides comprising nucleotide sequences encoding such an antibody or an antigen-binding fragment thereof, and expression vectors and host cells…

USPTO Abstract

The present invention provides an antibody, or an antigen-binding fragment thereof, which immunospecifically binds to human KIT, polynucleotides comprising nucleotide sequences encoding such an antibody or an antigen-binding fragment thereof, and expression vectors and host cells for producing such an antibody or an antigen-binding fragment thereof. The present invention also provides a conjugate and a pharmaceutical composition comprising the antibody or antigen-binding fragment of the invention.

Drugs covered by this patent

Patent Metadata

Patent number
EP3381943A1
Jurisdiction
EP
Classification
—
Expires
2018-10-03
Drug substance claim
No
Drug product claim
No
Assignee
Celldex Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.